First exit from Bluefront Capital I: Bio Marine sold to Ambienta
Bluefront Capital I has agreed to sell its 64 percent stake in Bio Marine to the Italian investment company Ambienta. It is the first exit from Bluefront’s first fund, which closed in 2021 and was invested across six companies.
Bluefront Capital I has agreed to sell its 64 percent holding in Bio Marine to Ambienta, an Italian investment company. The sale is the first exit from Bluefront’s first fund, which closed its books in 2021 with NOK 1 billion invested across six companies.
Bio Marine supplies equipment and systems for environmental control in both conventional and land-based fish farming. When Bluefront entered as an owner in 2022, the company was a niche supplier of oxygen and lighting solutions. Since then the product portfolio has been broadened to six product groups, adding environmental monitoring, lice skirts and systems for preventing and treating sea lice, while the customer base has widened from salmon to more than ten species.
Revenues grew from NOK 43.2 million to NOK 94.9 million over the ownership period, and profit before tax from NOK 7.6 million to NOK 24.9 million. The organisation has changed alongside it: headcount has roughly quadrupled, smaller acquisitions have been made to support the whole, a factory has been established in Lithuania, and the sales office at Son has been expanded considerably. Sales have also shifted towards frame agreements, giving better visibility on future revenue.
Interest in the company was strong, with bidders from five continents, which Bluefront reads as a sign that Norwegian-developed technology appeals to a broad field of international investors. Exiting after around five years of ownership is in line with Bluefront’s model.
Read the full article (in Norwegian): https://www.finansavisen.no/sjomat/2026/10/01/8384327/bluefront-equity-selger-bio-marine